Ryosuke Mihara

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue et al. · New England Journal of Medicine · 2017 · 574 citations · Full text

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

Kenji Kabashima, Masutaka Furue, Jon M. Hanifin et al. · Journal of Allergy and Clinical Immunology · 2018 · 237 citations · Full text

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co

O. Nemoto, M. Furue, Hidemi Nakagawa et al. · British Journal of Dermatology · 2015 · 186 citations · Full text

Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase <scp>II</scp> study

Ryosuke Mihara, Kenji Kabashima, Masutaka Furue et al. · The Journal of Dermatology · 2019 · 31 citations · Full text

Comparison of Direct and Indirect Laryngoscopes in Vomitus and Hematemesis Settings: A Randomized Simulation Trial

Ryosuke Mihara, Nobuyasu Komasawa, Sayuri Matsunami et al. · BioMed Research International · 2015 · 25 citations · Full text